Senate Acts to Combat Opioid Crisis, Improve Treatment Programs

Prohibits Co-Payments for Treatment at an Opioid Treatment Program: S.5690, sponsored by Senator Pete Harckham, prohibits insurance companies from imposing co-payments for treatment at an opioid treatment program.

Ensure Availability of Buprenorphine in Opioid Treatment Programs: S.6746A, sponsored by Senator Pete Harckham, requires facilities that provide treatment for substance use disorders to have at least one practitioner qualified to administer or prescribe buprenorphine to individuals in their care with substance use disorders related to opioids.

Provide Due Process Protections to Health Care Providers and Recipients: S.4486B, sponsored by Senator Pete Harckham, amends provisions relating to audit and review of medical assistance program funds by the Medicaid Inspector General; prohibits additional review without error or new information; requires application of rules in place at the time funds were paid to providers; requires notice to recipients of medical assistance funds of certain investigations.

Abuse Deterrent Technology Availability: S.4532, sponsored by Senator Samra Brouk, ensures that abuse-deterrent drugs approved by the FDA are accessible to patients and that insurance coverage does not disincentivize access for patients to drugs approved by the FDA as abuse-deterrent.

Nightlife Opioid Antagonist Program: S.8633A, sponsored by Senator Leroy Comrie, establishes the nightlife opioid antagonist program to allow certain establishments to apply and receive free of charge, at least ten doses of an opioid antagonist, to have on-site to be administered to patrons, staff or individuals in the case of an emergency.

Topher’s Law – Intensive Addiction Recovery and Mental Health Pilot Program: S.8244, sponsored by Senator Tim Kennedy, establishes an intensive addiction recovery and mental health integrated services pilot program to support two three-year demonstration programs that provide intensive addiction and mental health integrated services to individuals with significant addiction and mental health issues who have had multiple and frequent treatment episodes.

Erin’s Law – Public Facilities to Carry Opioid Antagonists: S.8708A, sponsored by Senator John Mannion, requires certain public facilities to maintain a stock of opioid antagonists in first aid kits and requires the education and training of staff persons employed in such places in the administration of opioid antagonists.

Consideration and Prescription of Non-Opioid Treatment Alternatives: S.4640, sponsored by Senator Gustavo Rivera, requires providers to consider, discuss and refer or prescribe (where appropriate and based upon clinical judgment) non-opioid treatment alternatives for the treatment of neuromusculoskeletal conditions.

http://www.viaspace.com/includes/magpierss-0.72/scripts/magpie_debug.php?url=http://feeds.feedburner.com/SyndicationSite

Comments are closed.